Tsuzuki S, Murano T, Watanabe H, Itoh Y, Miyashita Y, Shirai K
Department of Clinical Laboratory Medicine, Sakura General Hospital, Toho University.
Rinsho Byori. 1998 Aug;46(8):829-33.
Apolipoprotein E (apoE), which is reported to recognize the low density lipoprotein receptor and remnant receptor, mediates the delivery of cholesterol and other lipids to the cells all over the body. There are several phenotypes such as apoE2, apoE3 and apoE4. Recently, it is reported that apoE plays an important role in neurite outgrowth. To determine whether apoE phenotype is concerned in diabetic peripheral neuropathy, we investigated the incidence of apoE phenotypes in diabetic patients with peripheral neuropathy. The occurrence of retinopathy and nephropathy were not different in apoE2, apoE3 and apoE4. However, the frequency of diabetic neuropathy was higher in apoE4 than apoE2 and apoE3 (p < 0.05). Furthermore, as the stage of diabetic neuropathy advanced, the incidence of apoE4 increased. From these results we conclude that apoE phenotype influences the progress of diabetic peripheral neuropathy and that apoE4 contributes to the deterioration of diabetic peripheral neuropathy.
载脂蛋白E(apoE)据报道可识别低密度脂蛋白受体和残粒受体,介导胆固醇及其他脂质向全身细胞的转运。存在多种表型,如apoE2、apoE3和apoE4。最近,有报道称apoE在神经突生长中起重要作用。为确定apoE表型是否与糖尿病周围神经病变有关,我们调查了患有周围神经病变的糖尿病患者中apoE表型的发生率。在apoE2、apoE3和apoE4中,视网膜病变和肾病的发生率没有差异。然而,apoE4患者糖尿病神经病变的发生率高于apoE2和apoE3(p<0.05)。此外,随着糖尿病神经病变阶段的进展,apoE4的发生率增加。从这些结果我们得出结论,apoE表型影响糖尿病周围神经病变的进展,且apoE4促使糖尿病周围神经病变恶化。